G40.C0
Lafora progressive myoclonus epilepsy, not intractable
Clinical Classification Guidelines
Medical Intelligence & Overview
Lafora progressive myoclonus epilepsy is a rare inherited neurological disorder characterized by recurrent seizures, myoclonus (sudden muscle jerks), and progressive neurological decline. It typically manifests during adolescence and worsens over time, significantly impacting quality of life. Although this condition is complex, understanding its features can help in early recognition and management.
Causes & Symptoms
Clinical Causes: Genetic mutations in the EPM2A gene or the NHLRC1 gene Inherited in an autosomal recessive manner, meaning a person needs two copies of the mutated gene to be affected Lack of environmental factors contributing directly to disease development
Key Symptoms: Myoclonus: sudden, involuntary muscle jerks affecting different parts of the body Seizures: various types including generalized tonic-clonic, absence, or myoclonic seizures Progressive neurological decline leading to cognitive impairments Ataxia: impairments in coordination and balance Visual disturbances or decline in vision Behavioral and psychiatric changes over time
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical assessment, neurological examinations, and specialized tests. These include:
Treatment Protocols: While Lafora disease currently has no cure, treatment aims to reduce seizure frequency and manage symptoms. Strategies include:
Clinical Advice & FAQs
Billing Guidance
Is G40.C0 a billable ICD-10 code?
Yes, G40.C0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report G40.C0?
Clinical documentation must specify the nature of Lafora progressive myoclonus epilepsy, not intractable and any associated comorbidities for accurate reporting.
Cite this Clinical Reference